Dowling & Yahnke’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$247K Sell
4,875
-130
-3% -$7.02K 0.01% 330
2022
Q2
$269K Sell
5,005
-195
-4% -$10.7K 0.01% 323
2022
Q1
$300K Hold
5,200
0.01% 314
2021
Q4
$312K Hold
5,200
0.02% 315
2021
Q3
$287K Hold
5,200
0.02% 314
2021
Q2
$284K Sell
5,200
-325
-6% -$17.2K 0.02% 315
2021
Q1
$279K Hold
5,525
0.02% 300
2020
Q4
$272K Buy
5,525
+200
+4% +$9.44K 0.02% 291
2020
Q3
$242K Sell
5,325
-535
-9% -$24.2K 0.02% 286
2020
Q2
$253K Buy
5,860
+235
+4% +$9.92K 0.02% 280
2020
Q1
$211K Hold
5,625
0.02% 280
2019
Q4
$243K Sell
5,625
-75
-1% -$3.03K 0.02% 283
2019
Q3
$216K Sell
5,700
-225
-4% -$8.66K 0.02% 292
2019
Q2
$231K Buy
5,925
+250
+4% +$9.46K 0.02% 275
2019
Q1
$220K Sell
5,675
-700
-11% -$26.6K 0.02% 249
2018
Q4
$256K Buy
+6,375
New +$244K 0.03% 231

Other funds holding IYH

Dowling & Yahnke's IYH Position: Q3 2022 in Review

Dowling & Yahnke reduced its iShares US Healthcare ETF (IYH) stake by 2.6% in Q3 2022, selling an estimated $7.02K and leaving 4,875 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #330.

Dowling & Yahnke first reported a position in IYH in Q4 2018 and has held it in 16 quarters since. The position peaked at $312K in Q4 2021. 426 funds tracked by Wall St. Rank hold IYH as of Q3 2022.

  • Dowling & Yahnke held 4,875 shares of iShares US Healthcare ETF worth $247K as of Q3 2022.
  • Dowling & Yahnke sold 130 iShares US Healthcare ETF shares in Q3 2022, an estimated $7.02K.
  • iShares US Healthcare ETF made up 0.01% of Dowling & Yahnke's portfolio in Q3 2022, its #330 holding.
  • Dowling & Yahnke first reported a position in iShares US Healthcare ETF in Q4 2018 and has held it in 16 quarters since.
  • Dowling & Yahnke's iShares US Healthcare ETF position peaked at $312K in Q4 2021.
  • 426 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.